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Abstract.  Semliki Forest virus (SFV) and many other 
enveloped animal viruses enter cells by a membrane 
fusion reaction triggered by the low pH within the en- 
docytic pathway.  In vitro, SFV fusion requires choles- 
terol in the target membrane,  but the role of choles- 
terol in vivo is unknown.  In this paper, the infection 
pathway of SFV was studied in mammalian and inset 
cells substantially depleted of sterol.  Cholesterol- 
depleted cells were unaltered in their ability to bind, 
internalize,  and acidify virus, but were blocked in 
SFV fusion and subsequent virus replication.  Depleted 
cells could be infected by the cholesterol-independent 
vesicular stomatitis virus, which also enters cells via 
endocytosis and low pH-mediated fusion. The block in 
SFV infection was specifically reversed by cholesterol 
but not by cholestenone,  which lacks the critical 3B- 
hydroxyl group.  Cholesterol thus is central in the in- 
fection pathway of SFV, and may act in vivo to modu- 
late infection by SFV and other pathogens. 
N 
UMEROUS viral  and bacterial  pathogens  must gain 
access to the host cell cytoplasm in order to rep- 
licate. This entry pathway is best understood for en- 
veloped animal viruses such as Semliki Forest virus (SFV), 
which use endocytosis to infect a cell (reviewed in Kielian 
and Jungerwirth,  1990; White,  1990; Marsh and Helenius, 
1989; Kielian and Helenius,  1986).  SFV binds to plasma 
membrane receptors, is internalized  in coated pits and vesi- 
cles, and is delivered to the mildly acidic environment  of en- 
dosomes. The acid pH induces conformational  changes  in 
the SFV spike protein, and triggers the fusion of the viral and 
endosome membranes.  This critical  membrane fusion step 
releases the viral RNA into the cytoplasm and initiates infec- 
tion.  The fusion reaction is mediated by the viral spike gly- 
coprotein, a heterotrimer of two transmemhrane  glycopo!y- 
peptides,  E1 (50,786 D) and E2 (51,855 D), and a peripheral 
glycopolypeptide, E3 (11,369 D) (reviewed  in Schlesinger 
and Schlesinger,  1986; Simons  and Warren,  1984). 
Several lines of evidence argued that cholesterol might be 
playing  an important functional  role in SFV entry.  The in 
vitro fusion of SFV with artificial liposomes required choles- 
terol in the liposome membrane above a threshold  level of 
"~1  cholesterol per 4  phospholipid molecules (White and 
Helenius,  1980).  No other specific components except for 
low pH were necessary.  Studies with cholesterol analogues 
showed that the 3B-hydroxyl group is the critical portion of 
the sterol molecule, and suggested  that cholesterol's  action 
is not at the level of membrane fluidity 0Oelian and Helenius, 
1984). Lastly, the purified E1 ectodomain, a proteolytically 
truncated form of El, was found to require both low pH and 
a 3B-hydroxysterol in order to trigger its acid conformational 
1. Abbreviations used in thispaper: SFV, Semliki Forest virus; VSV, vesicu- 
lar stomatitis virus. 
change (Kielian and Helenius, 1985). Taken together,  these 
findings suggested a mechanistic  role for cholesterol in SFV 
fusion, but its relevance to virus infection  in vivo was un- 
known.  We have used sterol-depleted cells to examine  the 
role of cholesterol in the infective fusion of SFV with cellu- 
lar  membranes.  Our  results  showed  that  cholesterol  was 
specifically  required for infection of host cells by SFV, but 
not for infection by vesicular stomatitis  virus, a virus which 
also enters cells by endocytosis and low pH-triggered fusion. 
Thus, in nature the host specificity and tissue tropism of SFV 
and other intracellular  pathogens may be specifically modu- 
lated by cholesterol. 
Materials and Methods 
Virus and Cells 
A plaque-purified  stock of SFV was grown,  radiolabeled, and purified as 
previously  described, using baby hamster kidney  (BHK-21) cells (Kielian 
et al.,  1984). 
BHK-21 cells were cultured in Dulbecco's modified Eagle's medium con- 
raining 100 U/ml penicillin and streptomycin (DMEM), supplemented with 
5% FCS and 10% tryptose phosphate broth. CHO cells were cultured as 
monolayers  in alpha-MEM containing 10% FCS and 100 U/ml penicillin 
and streptomycin.  C6/36 cells,  a clonal line from Aedes albopictus (Igar- 
ashi, 1978), were cultured at 28°C in DMEM supplemented with 10% heat- 
inactivated  FCS. 
Depletion of  Cellular Cholesterol 
Lipoproteins were  removed from FCS by adsorption on Cab-O-Sit (Re- 
search  Products  International Corp.,  Prospect,  IL)  (Weinstein,  1979), 
which  reduced  total  serum cholesterol  levels  from  168  to  5.7  /~g/ml. 
I.xwastatin (a kind gift of Dr. A. Alberts, Merck Sharp and Dohme, Rahway, 
NJ) was saponified and dissolved (Langan and Volpe, 1986) and the concen- 
tration determined by absorbance at 239 nm (Alberts et al.,  1980). 
BHK-21 cells were partially depleted of cholesterol by growth for 3 d in 
DMEM with 3% delipidated FCS and 5% TPB.  During the last 24 h of 
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medium (Krieger 1983; Renaud et al., 1986). C6/36 cells were cholesterol 
depleted by gradually adapting to growthoin medium with delipidated se- 
rum, followed by culture, for at least 2 wk in DMEM with 3% heat- 
inactivated delipidated FCS (Silberkang et al., 1983). 
Steroid Repletion 
Cholesterol or cholestenone was complexed with BSA essentially by the 
procedure of Werb and Cohn (1972). In brief, 2 nag steroid dissolved in 1 
ml acetone was injected into 2 ml MEM containing 2 % BSA, the acetone 
evaporated under nitrogen, and the resulting emulsion sonicated on ice for 
2 rain with a Branson microtip (Branson Sonic Power Co., Danbury, CT) 
at a setting of 4. To quantitate the level of cell-associated steroid, emulsions 
were made with trace amounts of [7(n)-3H]cholesterol or cholestenone. 
[3H]Cholestenone was prepared by oxidation of [3H]cholesterol with cho- 
lesterol oxidase. The product was analyzed by thin layer chromatography 
on silica gel G in chloroform/methanol (50:1) (Lange and Ramos, 1983). 
96% of the radioactivity migrated at the position of cholestenone. 
For steroid enrichment, 0.215 mM steroid-BSA emulsion in C6/36 lipid- 
depleted media was added to depleted cells for 5 h at 28°C, followed by 
extensive washing. Enrichment was quantitated by trypsinizing the ceils, 
centrifuging through 5 ml of 5 % sucrose to separate nouassociated com- 
plexes, and determining the radioactivity in the cell pellet. Final levels of 
cell-associated steroid were '°6 #g cholesterol or 10/zg cholestenone per 
2 × 106 cells, which was 6-10-fold above the usual amount ~Jf cholesterol 
in this number of cells. Cholesterol repletion was also evaluated by staining 
with filipin, a cholesterol-specific fluorescent dye, exactly as described by 
Cadigan et al. (1990). 
Protein and Lipid Analysis 
100-ram plates of cells were washed and scraped into PBS, sonicated for 
1 rain on ice at a setting of 3 with a Branson microtip, and extracted by the 
method of Bligh and Dyer (1959). Media and FCS were extracted with 
petroleum ether (Werb and Cohn, 1971). Tritiated cholesterol was added 
to the extractions as an internal standard to quantitate recovery. Samples 
were dried completely under nitrogen and resuspended in spectral grade 
isopropanol containing 10% Triton X-100. Free and esterified cholesterol 
were determined by a fluorometric assay (Heider and Boyett, 1978), using 
an LS-5 fluorometer (Perkin-Elmer Corp., Pomona, CA). The protein con- 
centration of an aliquot of the sonicated cells was determined by a Lowry 
assay with 0.115% SDS (Lowry et al., 1951). 
figures shown are representative experiments with duplicates plates at each 
time point. All experiments were performed at least twice. 
Antibodies and Acid Specific lmmunoprecipitation 
The kinetics of endosome acidification in control and depleted C6/36 cells 
were analyzed by following the acid-induced conformational change in E1 
(Kielian et al., 1990; Kielian et ai., 1986). [35S]Methionine-labeled SFV 
was bound to cells as above, the cells warmed to 280C to permit endocyto- 
sis, the cells lysed at various times, and acid-converted E1 protein reacted 
with Ela-1, a conformation-specific monoclonal antibody (Kielian et al., 
1990). Immune complexes were precipitated with rabbit anti-mouse anti- 
body bound to fixed Staphylococcus aureus (Zysorbin; Zymed Laborato- 
ries, San Francisco, CA). Samples were analyzed by electrophoresis on 
nonreducing SDS gels, followed by fluorography (Kielian and Helenius, 
1985). 
Infection by SFV and VSV 
Infection by SFV and vesicular stomatitis virus (VSV) was assayed by quan- 
titating viral protein production in C6/36 cells that were pretreated under 
depleting or enrichment conditions. Cells were infected with either virus 
at 100 pfu/cell for 1 h at 280C in DMEM containing 0.2 % BSA and 10 mM 
Hepes. The inoculum was removed and the infection allowed to continue 
in C6/36 delipidated growth medium for a total of 3 h for VSV and 8 h for 
SFV. For labeling, the cells were incubated in methionine-deficient MEM 
for 15 min, pulsed for 30 min with 50 uCi/ml [35S]methionine, and chased 
for 15 min in DMEM with a 10-fold excess of methionine. Cells were lysed 
and immunoprecipitated with either a polyclonal serum against SFV spike 
proteins, or a polyclonal serum raised against VSV. Immunoprecipitates 
were analyzed by SDS-PAGE. Fluorograms were quantitated by densitome- 
try using a Quantimet Image Analysis System (Cambridge Instruments, 
Cambridge, England). 
SFV infection was also quantitated by measuring the incorporation of 
[3H]uridine into viral RNA, using quadruplicate cultures on coverstips. 
Depleted cells were preincubated with steroid-BSA complexes for 5 h as 
described above. All cells were then infected with SFV in DMEM contain- 
ing 0.2% BSA and 10 mM Hepes at a multiplicity of 75-90 pfu/cell for 5 
h, preincubated for 1 h with 2 #g/ml actinomycin D to block host cell RNA 
synthesis, and labeled for 6 h with 25 #Ci/ml [3H]uridine in actinomycin 
D. The incorporation of uridine into TCA-precipitable RNA was evaluated 
as previously described (Helenius et al., 1982). 
Cholesterol Oxidase Treatment of CHO Cells 
For maximal oxidation, CHO cells in suspension were prefixed with 2% 
glutaraldebyde for 15 rnin on ice, and treated for 1 h at 10°C with 8 U/ml 
cholesterol oxidase in 310 mM sucrose and 0.5 mM NaPO4, pH 7.4 (Lange 
and Ramos, 1983). To quantitate the conversion of cellular cholesterol to 
cholestenone, cells were metabolically labeled with [3H]mevalonolactone. 
Cells were first grown overnight in lipid-depleted CHO growth media to in- 
duce cholesterol synthesis. They were then pulsed 5 h at 370C with [3H] 
mevalonolactone and chased for 12 h in lipid depleted growth media. Cells 
were then oxidase treated, extracted, and cholesterol conversion was ana- 
lyzed by thin layer chromatography as described above. 
Binding, Fusion, Endocytosis, Penetration, and 
Degradation Assays 
Assays for these steps in the virus infection pathway have been previously 
described. For all assays, radiolabeled SFV was prebound to cells on ice 
with continuous shaking. To measure binding, cells were scraped and 
washed twice with ice-cold medium, followed by quantitation of cell- 
associated radioactivity (Marsh and Helenius, 1980). Ceils were treated at 
37°C with medium of the indicated pH to trigger virus-plasma membrane 
fusion; nonfused virus removed by either proteinase K or subtilisin diges- 
tion, and cell-associated radioactivity determined (Schmid et al., 1989; 
White et al., 1980). Cells were wanned to 37°C to initiate endocytosis, 
nonendocytosed virus removed by proteinase K digestion, and internalized 
virus quantitated (Marsh and Helenins, 1980). The lysosomai degradation 
of SFV was followed by determining the release of TCA-soluble [35S]me- 
thionine into the medium (Marsh and Helenius, 1980). Penetration assays 
monitored the accessibility of [3H]uridine-labeled SFV RNA to degrada- 
tion by ribonuclease added to cell homogenates (Helenius et al., 1982). The 
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Figure 1. Effect of cholesterol oxidase treatment on SFV fusion 
with CHO cells. CHO cells in suspension were pretreated with cho- 
lesterol oxidase under conditions which oxidized ~65 % of cellular 
cholesterol. [3~S]Methionine-labeled SFV was bound at 4°C to 
oxidase or mock-treated cells, and the cells were incubated for 2 
min at either pH 7.0 or 5.5 at 37°C to activate virus-plasma mem- 
brane fusion. Nonfused virus was removed by digestion with sub- 
tilisin, and fusion expressed as the percent of initial bound virus 
radioactivity which became protease resistant. Control cells bound 
23,342 cpm and oxidase-treated ceils bound 28,580 cpm. 
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Figure 2. Effect of cholesterol depletion on SFV fusion with BHK 
cells. BHK cells were depleted of cholesterol by growth in LDL- 
minus  medium  containing  4.5  #M  lovastatin  and  0.25  mM 
mevalonate.  [3sS]Methionine-labeled SFV  was bound  at 4°C  to 
control or depleted ceils, and treated for I min at 37°C with buffers 
at the  indicated  pH to activate virus-plasma membrane fusion. 
Nonfused virus was removed by digestion with proteinase K, and 
fusion expressed as the percent of initial bound virus radioactivity 
which became protease resistant.  Control cells bound 4,275 cpm 
and depleted cells bound 4,344 cpm. The radioactivity  in the pH 
7 sample represents both virus that has been endocytosed and an 
inherent background of proteinase  K-resistant bound virus. 
Results 
Cholesterol Depletion of  Mammalian Cells 
We explored several methods to assess the importance of 
cholesterol in the infectious pathway of SFV. Our first studies 
used either CHO cells or baby hamster kidney (BHK-21) 
cells.  Both cell lines  are productive mammalian hosts  for 
SFV and have been used to develop assays for the stages of 
endocytic viral entry. Using these well-established assays for 
the steps of virus entry and fusion, we hoped to be able to 
define the role of cholesterol in SFV infection. 
First, CHO cells in suspension were treated with the en- 
zyme cholesterol oxidase,  which  specifically oxidizes the 
3t-hydroxyl group on cholesterol to produce cholestenone 
(Lange and Ramos,  1983).  Other components of the mem- 
brane remain unaffected.  Radiolabeled SFV was bound to 
oxidase or mock-treated cells in the cold. The bound virus 
was treated briefly at low pH at 37°C to induce virus fusion 
with the plasma membrane. Fusion was followed by the re- 
Table L Cholesterol  Content and SFV Binding of  BHK 
and (76/36 Cells 
Cholesterol equivalents 
Cells  Free  Esterified  SFV binding 
/~g/mg protein  % control 
Control BHK  33.2 (3.6)*  [6]*  22.6 (1.2) [6]  100% [5] 
Depleted BHK  11.7  (0.7) [6]  3.7 (3.7) [6]  84.6% (13) [5] 
Control C6/36  16.7  (0.6) [5]  29.5 (1.7) [5]  100% [4] 
Depleted C6/36  <0.35  [5]  <0.61  [5]  137% (9) [4] 
* Standard deviation of the mean. 
t  Number of determinations. 
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Figure 3. Kinetics of SFV endocytosis and RNA penetration in con- 
trol and  cholesterol-depleted  BHK cells.  (,4) Endocytic  uptake. 
[3sS]Methionine-labeled SFV was prebound for 90 rain at 4°C to 
control or depleted BHK cells. The cells were warmed to 37°C for 
the indicated period, extracellular viruses stripped offby proteinase 
K digestion, and internalized virus radioactivity quantitated and ex- 
pressed as the percent of bound virus radioactivity which became 
protease  resistant.  The control  cells bound  18,324 cpm and the 
depleted cells bound 31,067 cpm. The counts at time 0 represent 
bound virus which was resistant to protease. (B) Penetration of vi- 
ral RNA into the cytoplasm.  [35H]Uridine-labeled SFV was pre- 
bound and internalized as in A. At the indicated time, the cells were 
homogenized and the accessibility of viral RNA to degradation by 
exogenous RNAse was assayed. Penetration is expressed as the per- 
cent of endocytosed viral RNA that was degraded by RNAse. The 
control cells had internalized 82,990 cpm by the 60-rain time point, 
and the depleted cells had internalized 33,873 cpm. 
sistance of the fused virus to protease stripping of  the plasma 
membrane (Schmid et al.,  1988; White et al.,  1980). After 
oxidation of ,x,65 % of cellular cholesterol, SFV fusion with 
oxidase-treated cells was completely blocked (Fig.  1). This 
result suggested that the sterol 3/~-hydroxyl group was re- 
quired for SFV fusion with a complex biological membrane. 
However, since in our hands significant oxidation of mem- 
brane  cholesterol  required  glutaraldehyde  fixation of the 
cells and treatment in low ionic strength buffers (Lange and 
Ramos, 1983), the oxidase system was not amenable to fur- 
ther analysis of early virus-cell interactions. Rather surpris- 
ingly, the fixed cells did support virus fusion, although it was 
considerably less efficient than fusion with untreated cells 
(compare Fig.  1 with Fig.  2). 
Mammalian cells can be depleted of cholesterol by using 
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Figure 4.  Kinetics of SFV RNA penetration  in  sterol-modified 
C6/36 cells. C6/36 cells were depleted of cholesterol by growth in 
3 % LDL-depleted fetal calf serum. Some depleted cultures were 
then enriched  in cholesterol or cholestenone by the addition of 
steroid-BSA complexes for 5  h.  [3H]Uridine-labeled SFV  was 
bound to all cells at 4°C, endocytosis initiated by warming to 28°C 
and the accessibility of viral RNA to degradation by exogenous 
RNAse assayed at the indicated time. Penetration is expressed as 
the percent of initial bound viral RNA which was degraded by 
RNAse. The counts bound to the four cell types ranged from 36,161 
to 39,390 cpm. 
drugs such as lovastatin to block the synthesis of mevalonate, 
the key intermediate of cholesterol biosynthesis (Alberts et 
al.,  1980). Cells are grown in lovastatin-containlng, LDL- 
deficient medium, and given a small amount of mevalonate 
to support synthesis of essential cellular isoprenoids (Krie- 
get,  1983). In the absence of cholesterol biosynthesis or a 
source of exogenous cholesterol, cholesterol is diluted out of 
the plasma membrane as the cells divide (Krieger, 1983). 
These conditions were modified to deplete BHK-21  cells 
(see Materials and Methods). After 24 h of culture under 
depleting conditions, total cholesterol levels were found to 
have declined to ~28 % those of control cells (Table I). Cell 
surface binding of SFV appeared unaffected by cellular cho- 
lesterol depletion (Table I), as predicted by the protein nature 
of the  receptor.  However, the low pH-triggered fusion of 
SFV with plasma membranes of the depleted cells was dra- 
matically decreased (Fig. 2). We then wanted to follow the 
steps of viral entry into the depleted cells. To assay endocy- 
tosis, radiolabeled SFV was bound to control and depleted 
cells at 4°C, the cultures wanned to 37°C at neutral pH to 
permit endocytosis, the virus remaining at the surface re- 
moved by protease stripping, and the internalized virus ra- 
dioactivity quantitated (Marsh and Helenlus,  1980). Endo- 
cytic uptake of virus was comparable in the two cell types, 
showing that the cells were basically healthy after substantial 
depletion (Fig. 3 A). Similarly, the kinetics of SFV degrada- 
tion were equivalent in the two cell types (data not shown). 
After arrival in the acid environment of the endosome, the 
fusion of virus with the endosome membrane releases the 
RNA into the cytoplasm. To measure this RNA penetration 
step, [3H]uridine-labeled SFV was bound to cells, the cul- 
tures warmed to permit endocytosis, homogenates prepared, 
and the susceptibility of viral RNA to digestion by RNAse 
evaluated  (Helenius  et al.,  1982).  RNA  penetration was 
significantly decreased in cholesterol-depleted cells, but a 
low rate of RNA release was still observed (Fig. 3 B). This 
result argued that sterol depletion decreased intracellular vi- 
rus fusion, but that the levels of sterol in the depleted cells 
were still  sufficient to permit some fusion.  Fusion at the 
plasma membrane in these cells had appeared to be com- 
pletely blocked (Fig. 2). This difference in the fusion block 
may indicate that artificially induced fusion at the plasma 
membrane is less efficient and requires more cholesterol, or 
that sterol depletion is more pronounced in the plasma mem- 
brane compared to the endosome membrane. 
Cholesterol Depletion of  a Mosquito Cell Line 
SFV, an alphavirus, is capable of infecting a wide variety of 
host cells in culture, and is transmitted in the ~vild by insect 
vectors (reviewed in Brown and Condreay, 1986), Insects are 
cholesterol auxotrophs, obtaining any necessary cholesterol 
from dietary sources (Nes and McKean, 1977). In contrast 
to mammalian cells, insect cell lines can be radically de- 
pleted of sterol simply by culture in LDL-depleted medium 
(Silberkang et al., 1983). Depletion produces no compensa- 
tory changes in cellular phospholipid or fatty acid composi- 
tion,  and unlike mammalian  cells,  insect cells  appear to 
suffer no adverse effects from long-term cholesterol deple- 
tion (Silberkang et al., 1983). We used a mosquito cell line, 
C6/36, as a host for SFV, and monitored the cholesterol lev- 
els in the cells after extended growth in LDL-deficient me- 
dium. As shown in Table I, both free and esterified choles- 
terol in depleted cells were below the limits of detection, or 
<2 % of control levels. The cells appeared morphologically 
normal, but did grow somewhat more slowly.  Again, SFV 
binding to the depleted cells was not inhibited, and was actu- 
ally somewhat higher than in control cells (Table I). 
Since sterol depletion was much more efficient in the in- 
sect cells, we continued our analysis of SFV cholesterol re- 
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Figure 5. Degradation of internalized SFV in control and depleted 
C6/36 cells.  [35S]Methionine-labeled  SFV was prebound for 90 
rain at 4°C  to control or depleted C6/36 cells.  The cells were 
warmed to 28°C for the indicated time, an aliquot of the medium 
removed and precipitated with 10% TCA, then the TCA-soluble  ra- 
dioactivity was determined and expressed as percent of the initial 
bound virus counts. Control cells bound.  69,602 cpm and depleted 
cells bound 84,944 cpm. At time 0, approximately 30 cpm were 
TCA soluble. 
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conformation in control  and depleted C6/36 
cells.  [35S]Methionine-labeled  SFV was  pre- 
bound for 90 rain at 4°C to control or depleted 
C6/36 cells. The cells were warmed to 28°C 
for the indicated time, lysed, and duplicate ali- 
quots analyzed by immunoprecipitation and gel 
electrophoresis. Controls included samples that 
were pretreated for 1 min at 28°C at pH 5.5 or 
7.0, and samples that were warmed to 28°C for 
120 rain in the presence of 10 #M monensin 
(MON). (A) Samples precipitated with a poly- 
clonal antibody against the SFV spike protein. 
(B) Samples precipitated with monoclonal an- 
tibody Ela-l, which recognizes the acid confor- 
mation of El. 
quirements using this system. The penetration of labeled vi- 
ral RNA into the cytoplasm of control and depleted C6/36 
cells was measured by RNAse sensitivity (Fig. 4), and com- 
pared to the amount of radioactive virus bound to the cells. 
In control cells, ,o50% of  the bound virus counts became ac- 
cessible to RNAse after 60 min of uptake at 28°C. Penetra- 
tion  of SFV  RNA  appeared to be totally blocked in  the 
depleted cells, with little or no RNA release after 90 min at 
28°C. We attempted to reverse this striking inhibition by the 
addition of exogenous cholesterol. BSA-steroid complexes 
were prepared using either cholesterol or the nonfusing ana- 
logue cholestenone (Werb and Cohn, 1972). The complexes 
were added to depleted cells for 5 h at a concentration of 2 
x  l0  -4 M,  which represents a  steroid excess of '~50-fold 
over the amount of cholesterol found in control cells. The as- 
sociation of the complexes with the cells was followed by 
adding trace amounts of radiolabeled steroid.  Association 
was maximal by 5 h, and both cholesterol and cholestenone 
became cell associated to levels above those of cholesterol 
in control cells (see Materials and Methods). However, the 
actual incorporation of steroid into the depleted cell mem- 
branes in unknown, and other studies have demonstrated that 
cholesterol is very slowly reincorporated into depleted mem- 
branes (Silberkang et al., 1983). Using filipin, a cholesterol- 
specific fluorescent dye (Cadigan et al., 1990), we found that 
there was also considerable heterogeneity in the amount of 
cholesterol uptake within the repleted cell population (data 
not shown). Our attempts to add back cholesterol more rap- 
idly or efficiently by using sterol-containing liposomes were 
unsuccessful.  We  therefore  chose  5  h  as  a  time  when 
significant  amounts  of  steroid-BSA  complexes  were  as- 
sociated with the ceils. To assay reversal of the penetration 
block, depleted cells were incubated with either steroid com- 
plex for 5 h, and then assayed for viral RNA entry (Fig. 4). 
Cholesterol  partially  reversed the  inhibition,  resulting  in 
RNA penetration to "~50% of the level seen in control cul- 
tures. No reversal was seen after incubation with choleste- 
none complexes. With increasing time of incubation, viral 
RNA became somewhat less accessible to RNAse in cho- 
lestenone enriched cells.  Since the uptake and degradation 
of SFV in cholestenone cells was similar to controls, the de- 
crease in RNAse susceptibility may be due to a stabilization 
of the virus membrane by cholestenone. 
Localization of the Block in Viral RNA Entry 
The inhibition of viral RNA entry could be blocked at any 
of  the  steps  in  the  endocytic  pathway  preceding  RNA 
penetration. Thus, an effect  of  cholesterol depletion on initial 
endocytic uptake,  transport within the endocytic vacuolar 
system, acidification of endosomes, or virus-endosome fu- 
sion would result in a block in RNA release. We were unable 
to assay endocytosis directly, since the virus-receptor inter- 
action in C6/36 cells appeared insensitive to any of a number 
of proteases  (data not shown).  We therefore followed the 
degradation of [35S]methionine-labeled virus as a  measure 
of endocytic uptake, transport to lysosomes, and lysosomal 
function. As shown in Fig. 5, degradation was identical in 
control and depleted cells. Essentially all virus radioactivity 
initially  bound  at  the  cell  surface  was  released  into  the 
medium in TCA-soluble form after 4  h  at 28°C. 
The unaltered lysosomal degradation suggested that acid- 
ification within the lysosomes of depleted cells was not sig- 
nificantly affected by the lack of  cholesterol. However, it was 
critical to demonstrate that acidification within endosomes 
was fully functional, since this provides the trigger for vi- 
rus-membrane fusion. For this assay,  we took advantage of 
the low pH-dependent conformational change in the E1 spike 
polypeptide (Kielian and Helenius,  1985).  This conforma- 
tional change is irreversible, occurs at the pH threshold of 
fusion, and results in altered protease sensitivity and recog- 
nition by acid-specific monoclonal antibodies. We have pre- 
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depleted C6/36 ceils. Control or depleted C6/36 cells 
were infected with (A)SFV or (B)VSV at a multiplic- 
ity of 100 pill per cell. After incubation for 8 (SFV) 
or 3 h (VSV), the cells were pulse-labeled with [35S]- 
methionine for 30 min, chased for 15 min, and har- 
vested.  The cell  lysates  were  immunoprecipitated 
with a polyclonal antibody against SFV spike pro- 
teins (A), or a polyclonal antibody against purified 
VSV(B), followed by analysis on SDS gels. 
viously demonstrated that the conformational change occurs 
during exposure of virus to endosomal acidity in BHK or 
CHO cells (Kielian et al.,  1986; Schmid et al.,  1989). 35S- 
labeled SFV was bound to control or depleted C6/36 cells 
and the cells warmed to 28°C for various times to permit en- 
docytosis. The cells were lysed and duplicate aliquots of the 
lysates were precipitated with a rabbit anti-spike antibody or 
with Ela-1,  an acid conformation-specific monoclonal anti- 
body (Kielian et al.,  1990).  As controls, bound virus was 
pretreated at either pH 7 or 5.5,  or virus was internalized 
in  the presence of 10  #M  monensin to block endosomal 
acidification (Marsh et al.,  1982). Fig. 6 A shows that the 
polyclonal antibody precipitated comparable amounts of ra- 
diolabeled virus polypeptides from control or cholesterol- 
depleted cell lysates after binding and uptake of SFV. A de- 
creased amount of  the E2 spike subunit was seen after 30 and 
60 min of endocytosis, especially in the depleted cells. This 
decrease resulted from lysosomal degradation, since it was 
blocked in cells that were treated with monensin during en- 
docytosis. When the samples were precipitated by monoclo- 
nal antibody Ela-l(Fig. 6 B), most of the bound E1 protein 
was in the acid conformation after surface treatment at pH 
5.5, but not pH 7. Comparison of the endocytosed samples 
(7-60 min) showed that E1 was rapidly converted to the acid 
conformation in both control and depleted cells. The kinetics 
of acidification in the two cell types were comparable. Con- 
version was due to endosomal acidification, since it occurred 
earlier than lysosomal degradation (Fig. 5) and was blocked 
Figure 8. SFV protein production in depleted and steroid-enriched 
C6/36 cells. Depleted C6/36 cells were incubated with cholesterol- 
or cholestenone-BSA complexes for 5 h. The cultures were then 
infected with SFV at a multiplicity of 100 pfu/cell for 8 h. Ceils 
were pulse labeled with [35S]methionine  for 30 min, chased for 15 
min, and the cell lysates analyzed by immunoprecipitation and gel 
electrophoresis, using a polyclonal antibody against the SFV spike 
protein. 
by monensin treatment (Fig. 6 B). Thus, both endocytosis 
and vacuolar acidification were unimpaired in sterol-depleted 
cells, and the inhibition of RNA entry was due to a block in 
SFV-endosome fusion. 
SFV Infection Is Blocked in Cholesterol-depleted 
C6/36 Cells 
Lastly, we wished to assay virus production by the depleted 
cells. The data up to this point predicted that SFV would be 
unable to replicate in the depleted cells due to the inability 
of the virus to fuse with a cholesterol-deficient membrane. 
Since cholesterol depletion might have general effects on the 
cells' biosynthetic machinery, infection by VSV, a rhabdovi- 
rus, was followed in parallel. This virus also enters ceils by 
endocytosis (Matlin et al.,  1982), has a fusion activity with 
a pH threshold similar to that of SFV (White et al.,  1981), 
and infects insect cells (Gillies and Stoller, 1980). However, 
VSV  fusion with liposomes is  independent of cholesterol 
(Eidelman, et al.,  1984). We chose to follow virus protein 
production in infected cells rather than the release of infec- 
tious virus particles, since reduced virus membrane choles- 
terol can have effects on VSV-infectivity (Pal et al.,  1988). 
Control and depleted C6/36 cells were infected with high 
multiplicities of either SFV for 8 h or VSV for 3 h. The in- 
fected cells were then pulse labeled with  [35S]methionine, 
lysed, and immunoprecipitated with antibodies raised against 
the SFV spike or purified VSV. 3 h after infection with VSV, 
both control and depleted cells produced large amounts of  vi- 
rus proteins, although the level of VSV protein was some- 
what  reduced in  depleted cells (Fig.  7  B).  Densitometry 
Table II. Viral RNA Synthesis In Sterol-modified 
C6/36 Cells 
[3H]Uridine  incorporation 
Cells*  Uninfected  Infected 
cpm/2  ×  10  J cells 
Control  5,324  32,393 
Depleted  3,696  3,796 
Depleted plus cholesterol  5,795  10,055 
Depleted plus cholestenone  3,499  3,763 
*Depleted cells were preincubated with steroid-BSA complexes for 5 h where 
indicated.  All cells were then infected with SFV, and the incorporation of uri- 
dine into RNA measured in the presence of actinomycin D (see Materials and 
Methods). 
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VSV  N  protein as the control cells. Both cell types were 
lysed by the VSV infection after 8 h (data not shown). 
SFV proteins were synthesized at high levels 8 h after ad- 
dition of virus to control C6/36 cells. In contrast, SFV pro- 
teins  were  undetectable  after  infection  and  labeling  of 
cholesterol-depleted cells (Fig. 7 A). This total block in vi- 
rus replication thus follows the block in SFV RNA penetra- 
tion into the depleted cell cytoplasm. The reversibility of this 
block  was  assayed  by  adding  cholesterol-  or  choleste- 
none-BSA complexes to the depleted ceils for 5 h, followed 
by infection with SFV and assay of either virus protein or 
RNA production. As shown in Fig. 8, depleted cells enriched 
with  cholesterol  supported  SFV  protein  production,  al- 
though again the reversal was not to the level of the control 
cells.  Densitometry showed that the  cholesterol-enriched 
cells synthesized SFV E1 and E2 proteins at 7-10% the level 
of control  cells.  No  SFV  proteins  were  produced  after 
cholestenone enrichment (<0.2 % by densitometry). Quanti- 
tation of virus RNA production by [3H]uridine  incorpora- 
tion showed that depleted cells synthesized no detectable 
SFV RNA (Table II). Cholesterol-BSA complexes restored 
the ability of the depleted cells to produce SFV RNA, at lev- 
els ~30% those of controls. No viral RNA production was 
detected in cholestenone-enriched cells. 
Discussion 
Taken together, these studies demonstrated that cholesterol 
is required in vivo to permit SFV fusion with the endosome 
membrane of the host cell. The fusion and infection block 
in cholesterol-depleted cells was at least partially overcome 
by the  addition of a  sterol  with the  critical  3/3-hydroxyl 
group. Previous studies suggest that this sterol requirement 
for SFV fusion is an essential feature of the target mem- 
brane,  rather  than  the  virus  membrane.  Thus,  although 
purified virus particles contain cholesterol in the virus mem- 
brane, they still require cholesterol in the target membrane 
in order to fuse (White and Helenius,  1980).  Conversely, 
SFV spike proteins reconstituted into phospholipid liposomes 
without sterol can still fuse with cholesterol-containing mem- 
branes (Marsh et al., 1983).  Our studies have shown that ir- 
reversible conformational changes occur in both the E1 and 
E2 subunits of the SFV spike protein upon exposure to low 
pH (Kielian et al., 1990;  Kielian and Heleuius, 1985).  For 
a proteolytically truncated form of El, this conformational 
change required the addition of  cholesterol liposomes during 
low pH treatment. Thus, sterol appears to serve an interac- 
tive role with the E1 subunit of the spike protein during fu- 
sion, rather than merely affecting target membrane proper- 
ties such as fluidity. We have not been able to detect a stable 
association of either E1 or E2 with cholesterol-containing 
liposomes  (Kielian and Heleuius,  1985).  Any interaction 
must therefore be either transitory or undetectable by our 
present assays. 
Our current working hypothesis for SFV fusion is that low 
pH-induced conformational changes in the E2 subunit and 
possibly in the E1 subunit act in concert to expose a previ- 
ously hidden site on El. This domain of E1 then interacts in 
a stereo-specific manner with cholesterol in the target mem- 
brane, allowing further conformational changes and leading 
to a disruption in the bilayer that triggers fusion. The role 
of  E2  is  hypothesized  from  its  efficient conformational 
change at the pH of fusion. In addition, E2 is synthesized as 
a precursor, p62, which must be cleaved in order to make 
the  spike  protein  fusion-competent (Lobigs  and  Garoff, 
1990;  Jain et al.,  1991). 
What could be the site of cholesterol interaction on the E1 
molecule? One possible candidate is a highly conserved 23 
amino acid long domain which lies 75 amino acid residues 
from the E1  NH2 terminus (Garoff et al.,  1980).  This re- 
gion is also strikingly apolar, and for these reasons has been 
suggested to be involved in fusion (Garoff  et al., 1980).  Mu- 
tation of specific amino acids within this conserved domain 
causes a dramatic acid shift in the pH threshold required to 
trigger fusion (Levy-Mintz, P., and M. Kielian, manuscript 
submitted for publication). This peptide domain could be the 
region of E1 that interacts with cholesterol. Studies with la- 
beled cholesterol may permit us to localize the interaction 
site. Perhaps more promising is the possibility that the cho- 
lesterol-depleted cells will allow the selection of virus mu- 
tants with altered cholesterol requirements. By analyzing the 
location of such mutations, we hope to obtain insights into 
the mechanism of cholesterol's action during SFV fusion. 
How common is a  cholesterol requirement in the entry 
pathway  of viruses  and  other  pathogens?  While  the  al- 
phaviruses that have been examined all appear to need cho- 
lesterol for fusion, other enveloped virus families that use 
endocytosis and low pH to infect cells do not have a similar 
sterol requirement. Influenza virus, a myxovirus, and VSV, 
a  rhabdovirus,  both  have  cholesterol-independent fusion 
mechanisms (White et al., 1982; Eidelman et al., 1984). In 
the case of influenza, fusion appears to be mediated by the 
low pH-triggered exposure of a hydrophobic fusion peptide, 
which is then capable of interacting with any hydrophobic 
substance including target membranes and detergents (re- 
viewed in Wiley and Skehel, 1987). It is interesting that cho- 
lesterol has been reported to be required for the fusion of 
Sendai virus, a paramyxovirus whose fusion protein bears 
structural  and  sequence  similarities  to  that  of influenza 
CKundrot et al.,  1983;  Hsu et al.,  1983;  Citovsky et al., 
1988). The in vivo cholesterol requirements for Sendai virus 
infection remain to be determined. 
Some  nonenveloped  viruses,  such  as  polio  virus,  are 
known to enter cells via endocytosis and a low pH-requiring 
membrane translocation step (Madshus et al.,  1984).  Polio 
virus will bind to membranes after treatment at low pH, but 
cholesterol is not a required component of the membrane 
(Lonberg-Holm et al., 1976).  An intriguing example is the 
nonenveloped  virus  rotavirus,  which  enters  cells  by  an 
undefined but apparently pH-independent mechanism (Kal- 
jot et al.,  1988; Keljo et al.,  1988).  There is sequence ho- 
mology between the 23 amino acid hydrophobic peptide of 
SFV and amino acids 384--401 of VP4, the rotavirus outer 
capsid protein (Mackow et al., 1988).  Immunoelectron mi- 
croscopy of rotavirus suggests that this region of VP4 is at 
the distal tip of the virus spike protein, where it could be in- 
volved in virus penetration (Prasad et al., 1990). One specu- 
lation on the role of this conserved sequence is that it inter- 
acts with cholesterol to mediate the transfer of the rotavirus 
genome across the host membrane. We are exploring this 
possibility using a cholesterol-depleted cell system. 
Numerous microbial parasites must also gain access to the 
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parallels to viral entry. The infection pathway of the faculta- 
tire intracellular bacterium Listeria monocytogenes is espe- 
cially provocative. These bacteria secrete a toxin, listerioly- 
sin O, which can lyse cells by interacting with cholesterol in 
the host membrane (Mengaud et al.,  1988; Tweten,  1988). 
The bacteria are phagocytosed by the host cell, and can only 
escape  from  the phagocytic  vacuole  when expressing  the 
gene for the toxin. The toxin activity has a pH optimum of 
5.5, which the bacteria may meet in the phagocytic vacuole 
of the host cell (MeUman et al.,  1986). L.  monocytogenes 
infection thus may also depend on the availability of choles- 
terol in the host call membrane, in a similar fashion to SFV 
infection. 
Most of the studies described in this paper used a cultured 
mosquito cell line. It is interesting that the course of SFV 
infection in an insect host such as the mosquito is different 
than infection of a vertebrate host. SFV lytically infects ver- 
tebrate cells, and can cause a lethal encephalitis upon injec- 
tion into mice (Griffin,  1986).  In contrast, the addition of 
SFV to mosquito cells in culture leads to a chronic infection 
without cell lysis, and infection of the mosquito host is not 
deleterious (Brown and Condreay,  1986).  Our results sug- 
gest that the localization and concentration of cholesterol in 
insects may contribute to the protection from lytic infection. 
The cholesterol in the initial blood meal might allow the pri- 
mary infection of SFV in mosquitoes, while decreased levels 
of cholesterol in other tissues could inhibit their subsequent 
infection by SFV. Other viral and bacterial pathogens with 
a sterol-dependent entry mechanism might also show effects 
of cholesterol on their infection or tissue tropism. 
One suggestion for the origin of viral fusion proteins has 
been that they evolved from host cell proteins which carry 
out cellular fusion reactions (White et al.,  1983). If the al- 
phavirus fusion protein evolved from a cellular protein, the 
cellular homologue would be expected to use cholesterol as 
an integral part of its function. There are endogenous cellu- 
lar proteins that have specific interactions and requirements 
for  cholesterol.  A  well-characterized  example  is  that  of 
HMG-CoA  reductase,  the rate-limiting enzyme of choles- 
terol biosynthesis (Goldstein and Brown, 1990). This ER en- 
zyme is down regulated by rapid degradation in the presence 
of an excess of cellular cholesterol. The increased turnover 
is due to an interaction of cholesterol with the transmem- 
brane domains of the enzyme (Jingami et al.,  1987).  Since 
cholesterol is not present in many insect tissues,  an insect 
cell homologue of the SFV fusion protein would presumably 
not rely on a sterol-requiring mechanism. In this light, it is 
interesting that HMG-CoA reductase in insect cells does not 
down-regulate in response to cholesterol, suggesting that in- 
deed the sterol interaction is missing (Brown et al.,  1983). 
Our findings of a sterol requirement for SFV fusion in vivo 
may be an example of a common motif between virus pro- 
teins and proteins of vertebrate cells. 
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